Skip to main content
. 2017 Oct 3;23(1):59–69. doi: 10.1038/mp.2017.190

Table 1. PET studies of dopaminergic function in non-human primates after ketamine administration compared to control.

Dopamine system studied Study Ketamine Ketamine dose and route of administration State of animal Duration of treatment When the outcome investigated Ligand Radiotracer administration Study design/ control group Analytical method Region of interest Na Outcome measure Change in dopamine measure after ketamine infusion compared to control condition
Dopamine synthesis Tsukada et al.36 Racemic 3 and 10 mg kg−1 h−1, i.v Anaesthetised Infusion throughout scan 30 mins prior to scan L-[ β -11C]DOPA i.v Within/ saline Graphical analysis (L-[ β -11C]DOPA) Str 4 Dopamine synthesis rate
Dopamine release Hashimoto et al., 201738 R and S-ketamine 0.5 mg kg−1 Sub-anaesthetised Infusion 40 mins After the end of infusion [11C]raclopride i.v Saline Reference tissue model Caudate/putamen 4 Δ D2/3 receptor binding potentialb 29% (S-Ketamine)
                            ↔ No change (R Ketamine)
  Tsukada et al.36 Racemic 3 and 10 mg kg−1 h−1, i.v Anaesthetised Infusion throughout scan 30 mins prior to scan [11C]raclopride i.v Within/ saline Kinetic analysis ([11C]raclopride) Str 4 Δ Binding potentialb
Dopamine transporter Tsukada et al.36 Racemic 3 and 10 mg kg−1 h−1, i.v Anaesthetised Infusion throughout scan 30 mins prior to scan [11C]β-CFT i.v Within/ saline Kinetic analysis ([11C]β-CFT) Str 4 DAT binding potential
  Yamamoto et al.34 Racemic 0.5 & 1.5 mg kg−1 Sub-anaesthetised Infusion 40 mins After the end of infusion [11C]β-CFT Bolus i.v Within/ saline Reference tissue model Ct, Str, Midbrain, Thal 5 DAT binding potential ↔ No change
  Harada et al.40 Racemic 3 mg kg−1 h−1 Anaesthetised Infusion throughout scan 60 mins before tracers [11C]β-CFT & [11C]β-CIT-FE i.v Within/ saline Kinetic analysis Str 3 DAT binding potential ([11C]β-CFT)
                            ↔ No change ([11C]β-CIT-FE)
  Tsukada et al.39 Racemic 3 and 10 mg kg−1 h−1, i.v Anaesthetised Infusion throughout scan 60 mins before tracers [11C]β-CFT & [11C]β-CIT-FE i.v Within/ saline Kinetic analysis Str 5 DAT binding potential (3 mg kg−1)

Abbreviations: Ct, cortex; DA, dopamine; DAT, dopamine transporter; i.m, intra muscular; i.v, intravenous; NA, not available; PET, positron emission tomography; Str, striatum; Thal, thalamus.

a

N the sample size represents the total number of animals used for the comparison in question.

b

Greater reduction in D2/D3 receptor binding potential after ketamine administration indicates greater dopamine release; significant increase, significant decrease and ↔no significant change.